Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Arcadia Biosciences Q3 2023 EPS $(1.89) Beats $(3.19) Estimate, Sales $1.60M Beat $1.55M Estimate

Author: Benzinga Newsdesk | November 09, 2023 05:14pm
Arcadia Biosciences (NASDAQ:RKDA) reported quarterly losses of $(1.89) per share which beat the analyst consensus estimate of $(3.19) by 40.75 percent. This is a 60.63 percent increase over losses of $(4.80) per share from the same period last year. The company reported quarterly sales of $1.60 million which beat the analyst consensus estimate of $1.55 million by 3.03 percent. This is a 14.96 percent decrease over sales of $1.88 million the same period last year.

Posted In: RKDA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist